Your browser doesn't support javascript.
loading
Proteinase-activated receptor 2 is involved in the behavioural changes associated with sickness behaviour.
Abulkassim, Roua; Brett, Ros; MacKenzie, Scott M; Bushell, Trevor J.
Affiliation
  • Abulkassim R; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, UK.
  • Brett R; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, UK.
  • MacKenzie SM; Institute of Cardiovascular and Medical Sciences, 126 University Place, University of Glasgow, Glasgow G12 8TA, UK.
  • Bushell TJ; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, UK. Electronic address: trevor.bushell@strath.ac.uk.
J Neuroimmunol ; 295-296: 139-47, 2016 06 15.
Article in En | MEDLINE | ID: mdl-27235359
Proteinase-activated receptor-2 (PAR2) is widely expressed in the CNS but whether it plays a key role in inflammation-related behavioural changes remains unknown. Hence, in the present study we have examined whether PAR2 contributes to behaviour associated with systemic inflammation using PAR2 transgenic mice. The onset of sickness behaviour was delayed and the recovery accelerated in PAR2(-/-) mice in the LPS-induced model of sickness behaviour. In contrast, PAR2 does not contribute to behaviour under normal conditions. In conclusion, these data suggest that PAR2 does not contribute to behaviour in the normal healthy brain but it plays a role in inflammation-related behavioural changes.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptor, PAR-2 / Illness Behavior Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals Language: En Journal: J Neuroimmunol Year: 2016 Document type: Article Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptor, PAR-2 / Illness Behavior Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals Language: En Journal: J Neuroimmunol Year: 2016 Document type: Article Country of publication: Netherlands